Alvopax®

Paclitaxel

Hold Hope On

Product Information

  • Proprietary Name: Alvopax®
  • Generic Name: Paclitaxel
  • Dosage Form: Vial
  • Strengths: 30 mg/5 ml, 100 mg/16.7 ml, 150 mg/25 ml, 300 mg/50 ml
  • Indications: Breast, Ovarian, Non-Small Cell Lung Cancer, AIDS-related Kaposi's Sarcoma
Download Leaflet

Oncology

Alvopax®

Paclitaxel is indicated for the treatment of breast, ovarian, non-small cell lung cancer, and AIDS-related kaposi's sarcoma.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.